Laboratorios Duncan – Miriam Martinez, CEO – Argentina
Miriam Martinez, CEO of Laboratorios Duncan and VP of CAPGEN, discusses the challenges her company faces as a generic manufacturer in a branded generic market and their plans for growth…
Address: Escalada 1454, Buenos Aires (C1407LED),Argentina
Tel: (5411) 4670-3474
Web: http://www.dromex.com.ar/index_en.php
Dromex is a company founded on the basis of commitment and business loyalty between customers and suppliers in the Argentinian market. Dromex has over 25 years of experience in supplying active principles for the pharmaceutical industry, as well as a highly qualified, proactive and efficient professional work team to offer a high-class service.
Dromex’s main business is representing manufacturers of active principles for the Argentinean pharmaceutical industry. We represent first-class companies who work under the highest quality standards, recognized worldwide.
Having its own warehouse, authorized by the ANMAT (local regulatory agency), enables Dromex to keep the raw materials with the highest demand. Dromex can therefore offer a wide range of products and services to meet all the needs of any laboratory.
Dromex has a subsidiary in Brazil, Dromex Brasil, which carries out the same type of business in that market.
Warehousing, representing manufacturers
Miriam Martinez, CEO of Laboratorios Duncan and VP of CAPGEN, discusses the challenges her company faces as a generic manufacturer in a branded generic market and their plans for growth…
KPMG’s lead healthcare consultant in Argentina gives an in-depth analysis of the long-term needs and objectives driving change in the industry, the structural issues that need to be overcome before…
The founder and president of Close Up International shares the story of the genesis, evolution, and growth of both his company and the prescription auditing industry, as well as his…
The executive director of Latin America’s largest plasma fractionation plant, a publicly-funded laboratory within the 400 year old National University of Cordoba, discusses the organization’s social responsibility as a provider and leader…
Over the course of a day of unprecedented collaboration, Argentina’s biotech industry came together to discuss the challenges facing their industry in Argentina and the region at BioArgentina 2014, an event…
Nicola Carusoni, PwC’s lead pharmaceutical partner in Buenos Aires, gives an overview of the key trends in the Argentinian pharma industry and discusses the importance of PwC as a partner to the…
Mauro Bono discusses the challenges of building a company from the interior of Argentina, and shares his assessment of the key issues driving and preventing change in the country’s pharmaceutical…
Glenmark’s country manager for Argentina discusses Argentina’s development expertise and how companies like Glenmark can capitalize on it through partnerships and collaborations. How did you become part of Glenmark,…
“We are glad to host, together with ETIF, an event bringing forward pharma technologies to Argentinian patients. We hope this collaboration with ETIF will be the first of many” – Ines…
President of the company, Alberto Alvarez-Saavedra, discusses the company’s transformation into a professional organization, and the strategy which has driven remarkable growth in recent years, and will continue to do so…
On behalf of the chamber of industry that represents research-based pharma and biopharma companies in Argentina, Ernesto Felicio discusses the current challenges facing the industry, and the chambers current agenda…
Long-term strategy is the name of the game for Janssen. Alejandro Smolje, the company’s director of finance for Latin America South, outlines how that strategy is implemented in Argentina and…
See our Cookie Privacy Policy Here
